BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20238193)

  • 1. Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Slart RH; Tio RA; van der Vleuten PA; Willems TP; Lubbers DD; Dierckx RA; van Veldhuisen DJ
    J Nucl Cardiol; 2010 Jun; 17(3):479-85. PubMed ID: 20238193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy.
    Tio RA; Slart RH; de Boer RA; van der Vleuten PA; de Jong RM; van Wijk LM; Willems T; Lubbers DD; Voors AA; van Veldhuisen DJ
    Neth Heart J; 2009 Dec; 17(12):470-4. PubMed ID: 20087450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
    van den Heuvel AF; van Veldhuisen DJ; van der Wall EE; Blanksma PK; Siebelink HM; Vaalburg WM; van Gilst WH; Crijns HJ
    J Am Coll Cardiol; 2000 Jan; 35(1):19-28. PubMed ID: 10636254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
    Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
    Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
    Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy.
    Naqvi TZ; Goel RK; Forrester JS; Siegel RJ
    J Am Coll Cardiol; 1999 Nov; 34(5):1537-44. PubMed ID: 10551704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
    Eichhorn EJ; Grayburn PA; Mayer SA; St John Sutton M; Appleton C; Plehn J; Oh J; Greenberg B; DeMaria A; Frantz R; Krause-Steinrauf H
    Circulation; 2003 Nov; 108(19):2336-41. PubMed ID: 14597587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy.
    Kobayashi M; Izawa H; Cheng XW; Asano H; Hirashiki A; Unno K; Ohshima S; Yamada T; Murase Y; Kato TS; Obata K; Noda A; Nishizawa T; Isobe S; Nagata K; Matsubara T; Murohara T; Yokota M
    JACC Cardiovasc Imaging; 2008 Nov; 1(6):718-26. PubMed ID: 19356507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
    Tio RA; Dabeshlim A; Siebelink HM; de Sutter J; Hillege HL; Zeebregts CJ; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Slart RH
    J Nucl Med; 2009 Feb; 50(2):214-9. PubMed ID: 19164219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
    Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
    Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
    Suwa M; Ito T; Kobashi A; Yagi H; Terasaki F; Hirota Y; Kawamura K
    Am Heart J; 2000 May; 139(5):905-12. PubMed ID: 10783226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Fukuchi K; Yasumura Y; Kiso K; Hayashida K; Miyatake K; Ishida Y
    J Nucl Med; 2004 Apr; 45(4):527-31. PubMed ID: 15073245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy.
    Stolen KQ; Kemppainen J; Kalliokoski KK; Karanko H; Toikka J; Janatuinen T; Raitakari OT; Airaksinen KE; Nuutila P; Knuuti J
    Am J Cardiol; 2004 Jan; 93(1):64-8. PubMed ID: 14697468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
    Neglia D; De Maria R; Masi S; Gallopin M; Pisani P; Pardini S; Gavazzi A; L'abbate A; Parodi O
    Heart; 2007 Jul; 93(7):808-13. PubMed ID: 17237134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study.
    Masci PG; Marinelli M; Piacenti M; Lorenzoni V; Positano V; Lombardi M; L'Abbate A; Neglia D
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):482-90. PubMed ID: 20463209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers.
    Hasegawa S; Kusuoka H; Maruyama K; Nishimura T; Hori M; Hatazawa J
    J Am Coll Cardiol; 2004 Jan; 43(2):224-33. PubMed ID: 14736441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of myocardial perfusion reserve measurements using regularized factor images of H(2)(15)O dynamic PET scans.
    Frouin F; Merlet P; Bouchareb Y; Frouin V; Dubois-Randé JL; De Cesare A; Herment A; Syrota A; Todd-Pokropek A
    J Nucl Med; 2001 Dec; 42(12):1737-46. PubMed ID: 11752068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.